Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
Abstract
Decipher (Decipher Biosciences Inc) is a genomic classifier (GC) developed to estimate the risk of distant metastasis (DM) after radical prostatectomy (RP) in patients with prostate cancer.To validate the GC in the context of a randomized phase 3 trial.This ancillary study used RP specimens from the phase 3 placebo-controlled NRG/RTOG 9601 randomized clinical trial conducted from March 1998 to March 2003. The specimens were centrally reviewed,...
Paper Details
Title
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
Published Date
Apr 1, 2021
Journal
Volume
7
Issue
4
Pages
544 - 544
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History